Cardiomyopathy CT: Difference between revisions
Jump to navigation
Jump to search
Lina Yaqoub (talk | contribs) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cardiomyopathy}} | {{Cardiomyopathy}} | ||
Cardiac CT has been increasingly recognized as a tool to assess for ischemic heart disease in those with intermediate pre-test probability for coronary artery disease. Cardiac CT can identify calcifications and blockages in the coronary vessels. It may also detect associated cardiac anomalies. | Cardiac CT has been increasingly recognized as a tool to assess for ischemic heart disease in those with intermediate pre-test probability for coronary artery disease. Cardiac CT can identify calcifications and blockages in the coronary vessels. It may also detect associated cardiac anomalies. | ||
| Line 17: | Line 16: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 16:15, 31 December 2018
|
Cardiomyopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Guidelines |
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy |
|
Case Studies |
|
Cardiomyopathy CT On the Web |
|
American Roentgen Ray Society Images of Cardiomyopathy CT |
Cardiac CT has been increasingly recognized as a tool to assess for ischemic heart disease in those with intermediate pre-test probability for coronary artery disease. Cardiac CT can identify calcifications and blockages in the coronary vessels. It may also detect associated cardiac anomalies.